Peter Hu

Initiating Insulin Therapy in Type 2 Diabetes

Philip Raskin, Elsie Allen, Priscilla Hollander et al. · Diabetes Care · 2005 · 560 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17

Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in transplantation-ineligible patients with newly diagnosed mantle cell lymphoma: final overall survival results of a randomised, open-label, phase 3 study

Tadeusz Robak, Jie Jin, Halyna Pylypenko et al. · The Lancet Oncology · 2018 · 140 citations

Medicine, Hematology, Oncology +15

Pentosan Polysulfate Sodium for Treatment of Interstitial Cystitis/Bladder Pain Syndrome: Insights from a Randomized, Double-Blind, Placebo Controlled Study

J. Curtis Nickel, Sender Herschorn, Kristene Whitmore et al. · The Journal of Urology · 2014 · 119 citations

Medicine, Pharmacology, Urology +9

Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Siltuximab in High-Risk Smoldering Multiple Myeloma

Timothy Brighton, Amit Khot, Simon J. Harrison et al. · Clinical Cancer Research · 2019 · 70 citations

Medicine, Immunology, Pharmacotherapy +17

Safety and Efficacy of Delayed Release Rabeprazole in 1‐ to 11‐Month‐Old Infants With Symptomatic GERD

Sunny Z. Hussain, Jarosław Kierkuś, Peter Hu et al. · Journal of Pediatric Gastroenterology and Nutrition · 2013 · 34 citations

Medicine, Pharmacology, Pharmacotherapy +15